Устойчивость к противомикробным препаратам

Antimicrobial Resistance Multi-Partner Trust Fund (AMR MPTF)

Status: Ongoing

Donor: Multi-donor: Governments of Netherlands, the United Kingdom (using UK aid funding through the Fleming Fund), Sweden (including through the Swedish International Development Cooperation Agency – Sida) as well as Germany (through the German Agency for International Cooperation – GIZ)

Target Countries: Global eligibility. For Asia Pacific Region on-going projects in Cambodia and Indonesia, pipeline projects in Bangladesh and Mongolia.

Period:  AMR MPTF started in 2019 and currently continues to end 2030.  Individual projects 3 years duration.

Objectives:  The AMR MPTF is a significant instrument aligned with the Quadripartite Strategic Framework for collaboration on AMR which has as its goal, preserving antimicrobial efficacy and ensuring sustainable and equitable access to antimicrobials for responsible and prudent use in human, animal and plant health contributing to achieving the SDGs.  

There are two supporting objectives:

OBJECTIVE 1: Optimize the production and use of antimicrobials along the whole life cycle from research and development to disposal

OBJECTIVE 2: Decrease the incidence of infection in humans, animals and plants to reduce the development and spread of AMR 

Activities and outputs:

This wide-ranging project asks countries to choose from the following outputs: 

  • Improved capacities for designing and implementing AMR-related policy frameworks, investments plans and programmes
  • Improved capacities for mainstreaming and costing AMR as well as changes in practices to minimize AMR
  • Engagement plans with stakeholder groups implemented
  • Systems for generating, analysing and interpreting data on AMR, AMU/AMC patterns developed or strengthened
  • Systems for biosecurity and IPC strengthened
  • System for optimized use of antimicrobials strengthened in critical human/animal sectors
  • Improved capacity to design awareness-raising, behaviour change and educational activities

Main achievements: 

Many projects are in early stages of implementation.  The main achievements to date are:

  • Closer quadripartite collaboration and intensified prioritization and planning with government partners
  • Tools and advice to countries from global programmes on environment, regulatory review and support, integrated surveillance (Tripartite Integrated System for Surveillance on AMR and Antimicrobial Use – TISSA), and M&E
  • Inter-country and inter-region exchange and support on technical areas such as antimicrobial stewardship, integrated surveillance and multi-sectoral governance

 

 

 

Share this page